NCT02726386: A trial that was reported late by NeuroDerm Ltd.
This trial has reported, although it was 918 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT02726386 |
|---|---|
| Title | A Multicenter, International, Open-label, Safety Study of ND0612, a Solution of Levodopa/Carbidopa Delivered Via a Pump System as a Continuous Subcutaneous Infusion in Subjects With Advanced Parkinson's Disease |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | May 4, 2016 |
| Completion date | Sept. 9, 2019 |
| Required reporting date | Sept. 8, 2020, midnight |
| Actual reporting date | March 16, 2023 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 918 |